Compounders Research Compare

Edesa Biotech, Inc.(EDSA)

Biotechnology · Markham, ON

$3.87-0.04 (-1.15%)

Delayed quote: Oct 6, 2026, 10:38 AM EDT

About Edesa Biotech, Inc.

Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.

Markham, ON

17 employees

www.edesabiotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Pardeep Nijhawan

View full financials

Edesa Biotech (EDSA) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T14:56:41.857Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:56:41.857Z.

Quote observation: 2026-10-06T14:38:49.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.69
Quote price: 3.865

FMP input reference: 4a3a0e03002c1ec33ed026058caacdcc2374dd3411b27b5cd001974e391cfa1f

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

EDSA Earnings Yield Metrics

EARNINGS YIELD

N/A

EDSA Competitors' Earnings Yield

Edesa Biotech, Inc.

Current

Market Cap

$37.23M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

iTonic Holdings Ltd.

Market Cap

$37.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DocGo Inc.

Market Cap

$36.48M

Earnings Yield

N/A

TTM Avg

6.97%

3Y Avg

4.38%

5Y Avg

4.29%

Elicio Therapeutics, Inc.

Market Cap

$36.42M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Harvard Bioscience, Inc.

Market Cap

$39.28M

Earnings Yield

N/A

TTM Avg

0.70%

3Y Avg

1.26%

5Y Avg

6.45%

Incannex Healthcare Limited

Market Cap

$39.24M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Accuray Incorporated

Market Cap

$35.53M

Earnings Yield

N/A

TTM Avg

0.42%

3Y Avg

0.42%

5Y Avg

1.38%

Nephros, Inc.

Market Cap

$39.63M

Earnings Yield

4.35%

TTM Avg

2.93%

3Y Avg

2.58%

5Y Avg

2.58%

BriaCell Therapeutics Corp.

Market Cap

$35.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Elutia Inc

Market Cap

$34.42M

Earnings Yield

120.73%

TTM Avg

90.36%

3Y Avg

90.36%

5Y Avg

90.36%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Edesa Biotech, Inc. (EDSA)	$37.23M	N/A	N/A	N/A	N/A
iTonic Holdings Ltd. (ITOC)vs ›	$37.06M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$36.48M	N/A	6.97%	4.38%	4.29%
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.42M	N/A	N/A	N/A	N/A
Harvard Bioscience, Inc. (HBIO)vs ›	$39.28M	N/A	0.70%	1.26%	6.45%
Incannex Healthcare Limited (IXHL)vs ›	$39.24M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$35.53M	N/A	0.42%	0.42%	1.38%
Nephros, Inc. (NEPH)vs ›	$39.63M	4.35%	2.93%	2.58%	2.58%
BriaCell Therapeutics Corp. (BCTX)vs ›	$35.06M	N/A	N/A	N/A	N/A
Elutia Inc (ELUT)vs ›	$34.42M	120.73%	90.36%	90.36%	90.36%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics